Normas Clínicas/Clinical Guidelines
Recomendações para o diagnóstico e tratamento das tuberculoses latente e activa nas doenças inflamatórias articulares candidatas a terapêutica com fármacos inibidores do factor de necrose tumoral alfa. Revisão de Março de 2008*
Recommendations for the diagnosis and treatment of latent and active tuberculosis in inflammatory joint diseases candidates for therapy with tumor necrosis factor alpha inhibitors – March 2008 update*
Read
5905
Timeswas read the article
2340
Total PDF
3565
Total HTML
Article information
ISSN: 08732159Original language: Portuguese
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 6 | 4 | 10 |
| 2025 5 | 67 | 53 | 120 |
| 2025 4 | 74 | 35 | 109 |
| 2025 3 | 37 | 29 | 66 |
| 2025 2 | 33 | 35 | 68 |
| 2025 1 | 28 | 37 | 65 |
| 2024 12 | 21 | 44 | 65 |
| 2024 11 | 34 | 73 | 107 |
| 2024 10 | 36 | 48 | 84 |
| 2024 9 | 32 | 44 | 76 |
| 2024 8 | 49 | 38 | 87 |
| 2024 7 | 31 | 36 | 67 |
| 2024 6 | 22 | 24 | 46 |
| 2024 5 | 33 | 29 | 62 |
| 2024 4 | 26 | 37 | 63 |
| 2024 3 | 28 | 22 | 50 |
| 2024 2 | 29 | 22 | 51 |
| 2024 1 | 30 | 26 | 56 |
| 2023 12 | 22 | 23 | 45 |
| 2023 11 | 23 | 26 | 49 |
| 2023 10 | 19 | 22 | 41 |
| 2023 9 | 18 | 27 | 45 |
| 2023 8 | 23 | 18 | 41 |
| 2023 7 | 20 | 32 | 52 |
| 2023 6 | 23 | 25 | 48 |
| 2023 5 | 23 | 22 | 45 |
| 2023 4 | 21 | 19 | 40 |
| 2023 3 | 19 | 25 | 44 |
| 2023 2 | 20 | 17 | 37 |
| 2023 1 | 27 | 18 | 45 |
| 2022 12 | 21 | 24 | 45 |
| 2022 11 | 30 | 32 | 62 |
| 2022 10 | 36 | 18 | 54 |
| 2022 9 | 23 | 32 | 55 |
| 2022 8 | 26 | 36 | 62 |
| 2022 7 | 24 | 34 | 58 |
| 2022 6 | 13 | 23 | 36 |
| 2022 5 | 26 | 29 | 55 |
| 2022 4 | 22 | 24 | 46 |
| 2022 3 | 26 | 29 | 55 |
| 2022 2 | 20 | 26 | 46 |
| 2022 1 | 28 | 40 | 68 |
| 2021 12 | 31 | 39 | 70 |
| 2021 11 | 24 | 24 | 48 |
| 2021 10 | 24 | 37 | 61 |
| 2021 9 | 21 | 29 | 50 |
| 2021 8 | 27 | 18 | 45 |
| 2021 7 | 26 | 24 | 50 |
| 2021 6 | 20 | 25 | 45 |
| 2021 5 | 32 | 25 | 57 |
| 2021 4 | 76 | 32 | 108 |
| 2021 3 | 55 | 23 | 78 |
| 2021 2 | 36 | 21 | 57 |
| 2021 1 | 27 | 11 | 38 |
| 2020 12 | 21 | 7 | 28 |
| 2020 11 | 36 | 20 | 56 |
| 2020 10 | 21 | 8 | 29 |
| 2020 9 | 61 | 27 | 88 |
| 2020 8 | 56 | 20 | 76 |
| 2020 7 | 92 | 16 | 108 |
| 2020 6 | 65 | 19 | 84 |
| 2020 5 | 68 | 17 | 85 |
| 2020 4 | 76 | 9 | 85 |
| 2020 3 | 50 | 16 | 66 |
| 2020 2 | 49 | 25 | 74 |
| 2020 1 | 59 | 23 | 82 |
| 2019 12 | 53 | 17 | 70 |
| 2019 11 | 74 | 16 | 90 |
| 2019 10 | 53 | 12 | 65 |
| 2019 9 | 54 | 23 | 77 |
| 2019 8 | 72 | 23 | 95 |
| 2019 7 | 46 | 13 | 59 |
| 2019 6 | 39 | 9 | 48 |
| 2019 5 | 43 | 25 | 68 |
| 2019 4 | 37 | 21 | 58 |
| 2019 3 | 64 | 16 | 80 |
| 2019 2 | 87 | 15 | 102 |
| 2019 1 | 67 | 18 | 85 |
| 2018 12 | 42 | 12 | 54 |
| 2018 11 | 6 | 3 | 9 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 13 | 4 | 17 |
| 2018 8 | 37 | 22 | 59 |
| 2018 7 | 28 | 25 | 53 |
| 2018 6 | 42 | 17 | 59 |
| 2018 5 | 45 | 17 | 62 |
| 2018 4 | 35 | 34 | 69 |
| 2018 3 | 42 | 27 | 69 |
| 2018 2 | 15 | 14 | 29 |
| 2018 1 | 37 | 10 | 47 |
| 2017 12 | 26 | 12 | 38 |
| 2017 11 | 34 | 13 | 47 |
| 2017 10 | 26 | 17 | 43 |
| 2017 9 | 18 | 15 | 33 |
| 2017 8 | 25 | 14 | 39 |
| 2017 7 | 12 | 5 | 17 |
| 2017 6 | 16 | 10 | 26 |
| 2017 5 | 31 | 6 | 37 |
| 2017 4 | 8 | 3 | 11 |
| 2017 3 | 16 | 4 | 20 |
| 2017 2 | 12 | 1 | 13 |
| 2017 1 | 10 | 4 | 14 |
| 2016 12 | 8 | 7 | 15 |
| 2016 11 | 7 | 2 | 9 |
| 2016 10 | 9 | 12 | 21 |
| 2016 9 | 6 | 2 | 8 |
| 2016 8 | 4 | 1 | 5 |
| 2016 7 | 7 | 5 | 12 |
| 2016 5 | 7 | 8 | 15 |
| 2016 4 | 1 | 1 | 2 |
| 2016 3 | 1 | 4 | 5 |
| 2016 2 | 5 | 9 | 14 |
| 2016 1 | 8 | 9 | 17 |
| 2015 12 | 6 | 6 | 12 |
| 2015 11 | 3 | 2 | 5 |
| 2015 10 | 3 | 3 | 6 |
Show all
